Marta Fornos
Luke Minion
Jason Yan
Han Swinkels
Boehringer Ingelheim Vetmedica, Inc. (BIVI), announces the 2013 recipients of its annual Advancement in PRRS Research Awards. This year, BIVI awarded $75,000 to support three separate studies by independent swine researchers and practitioners in their investigations of novel ways to diagnose, control and eliminate this costly swine disease.
ARTES Biotechnology has announced a collaboration with global pharmaceutical company, Boehringer Ingelheim Animal Health. ARTES Biotechnology specialises in recombinant protein production, process and vaccine development from microbial expression systems. ARTES’ expression system Hansenula polymorpha is the preferred technology for affordable mass vaccination and recommended by the World Health Organization (WHO) for these purposes. In combination with ARTES’ METAVAX® platform, this offers a new, unique and economical approach to low-cost mass production of safe and effective vaccines required in the veterinary field.
Date: November 7th to 9th 2017Place: De Moines, Iowa (USA)
Get the latest news on Swine Health Subscribe to our newsletter